Filing search / Petros Pharmaceuticals, Inc. / "Raw Materials"

424B4

PTPI Petros Pharmaceuticals, Inc.

19 Feb 25

Prospectus supplement with pricing info

5:22pm

of 83% raw materials and 17% production labor. Cost of sales decreased by $525,127 or 36% during the nine months ended September 30, 2024, compared … for the Medical Device segment for the three months ended September 30, 2024, consisted of 80% raw materials and 20% production labor. Cost of sales

POS AM

0xgc7z fzb

14 Oct 22

Prospectus update (post-effective amendment)

4:05pm